Breaking News Instant updates and real-time market news.

NTGN

Neon Therapeutics

$1.32

-0.01 (-0.75%)

14:42
11/26/19
11/26
14:42
11/26/19
14:42

Neon Therapeutics downgraded to Underweight from Overweight at Morgan Stanley

Morgan Stanley downgraded Neon Therapeutics to Underweight from Overweight with a $1 price target.

NTGN Neon Therapeutics
$1.32

-0.01 (-0.75%)

07/26/19
07/26/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dentsply Sirona (XRAY) initiated with an In Line at Evercore ISI. 2. BridgeBio (BBIO) initiated with an Outperform at Raymond James. 3. Crispr Therapeutics (CRSP) initiated with a Buy at Canaccord. 4. GeoPark (GPRK) initiated with a Buy at GMP Securities. 5. Neon Therapeutics (NTGN), Gritstone Oncology (GRTS), and Cue Biopharma (CUE) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/19
BOFA
11/13/19
DOWNGRADE
BOFA
Neutral
Neon Therapeutics downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Neon Therapeutics to Neutral from Buy.
11/13/19
BOFA
11/13/19
DOWNGRADE
Target $2
BOFA
Neutral
Neon Therapeutics downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Alec Stranahan downgraded Neon Therapeutics to Neutral from Buy with a $2.00 price target after its Q3 results. The analyst says the company expects its cash to fund operations into June 2020, adding that while he still sees potential for its neoantigen-based approach to augment currently approved immunotherapies, its clinical candidates are far from market.
11/21/19
MZHO
11/21/19
NO CHANGE
Target $7
MZHO
Buy
Neon Therapeutics price target lowered to $7 from $21 at Mizuho
Mizuho analyst Salim Syed lowered his price target for Neon Therapeutics to $7 from $21 following the company's restructuring announcement. The analyst, however, says Neon now has a stronger execution plan in place and a more streamlined story. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

EMN

Eastman Chemical

$75.68

0.67 (0.89%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Hot Stocks
Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Earnings
Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Upgrade
Epizyme rating change  »

Epizyme upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

ESTA

Establishment Labs

$24.31

0.32 (1.33%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Hot Stocks
Establishment Labs reaches one million Motiva implants milestone »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDT

IDT Corp

$7.47

0.26 (3.61%)

16:34
12/05/19
12/05
16:34
12/05/19
16:34
Earnings
IDT Corp reports Q1 EPS 10c vs. (2c) last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

KODK

Kodak

$2.59

0.085 (3.39%)

16:33
12/05/19
12/05
16:33
12/05/19
16:33
Hot Stocks
Kodak's Karfunkel acquires over 4.4M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAC

GAP Airports

$99.66

-1.12 (-1.11%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
GAP Airports reports November traffic up 10.1% »

GAP Airports announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$19.49

0.7 (3.73%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
St. Joe, HomeCorp to build additional 120 apartment homes in Panama City Beach »

The St. Joe Company and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.44

-0.17 (-0.87%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
Alector announces FDA fast track designation granted to AL001 for dementia »

Alector announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGLN

Magellan Health

$76.79

-0.12 (-0.16%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Magellan Health names James Murray as President and COO »

Magellan Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWIR

Sierra Wireless

$9.15

0.12 (1.33%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Sierra Wireless CFO Dave McLennan retiring in mid-2020 »

Sierra Wireless CFO Dave…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

ASR

Asur

$167.79

-1.88 (-1.11%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Asur reports total November passenger traffic up 7.3% »

Asur announced that total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$25.05

0.92 (3.81%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Integrated Core Strategies reports 5.1% passive stake in Axonics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$313.10

1 (0.32%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Earnings
Cooper Companies sees Q1 EPS $2.65-$2.75, consensus $2.97 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Options
Preliminary option volume of 14.7M today »

Preliminary option volume…

COO

Cooper Companies

$312.96

0.86 (0.28%)

16:28
12/05/19
12/05
16:28
12/05/19
16:28
Earnings
Cooper Companies sees FY20 EPS $12.60-$13.30, consensus $13.10 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Downgrade
Audentes Therapeutics, Astellas Pharma rating change  »

Audentes Therapeutics…

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Earnings
Zumiez provides Q4 quarter to date sales update »

With the Thanksgiving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:26
12/05/19
12/05
16:26
12/05/19
16:26
Earnings
Zumiez sees FY19 EPS $2.38- $2.46, consensus $2.16 »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

COO

Cooper Companies

$312.96

0.86 (0.28%)

16:25
12/05/19
12/05
16:25
12/05/19
16:25
Earnings
Cooper Companies reports Q4 EPS $3.30, consensus $3.27 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.